These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23527297)

  • 1. Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro.
    Zhi F; Dong H; Jia X; Guo W; Lu H; Yang Y; Ju H; Zhang X; Hu Y
    PLoS One; 2013; 8(3):e60034. PubMed ID: 23527297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells.
    Wu J; Wang YS; Yang XY; Liu YY; Yang JR; Yang R; Zhang N
    Nanotechnology; 2012 Sep; 23(35):355101. PubMed ID: 22875697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound.
    Bai M; Shen M; Teng Y; Sun Y; Li F; Zhang X; Xu Y; Duan Y; Du L
    Oncotarget; 2015 Dec; 6(41):43779-90. PubMed ID: 26575421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy.
    Jin W; Wang Q; Wu M; Li Y; Tang G; Ping Y; Chu PK
    Biomaterials; 2017 Jun; 129():83-97. PubMed ID: 28329693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
    Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
    Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
    Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
    Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy.
    Wu M; Liu X; Jin W; Li Y; Li Y; Hu Q; Chu PK; Tang G; Ping Y
    J Control Release; 2017 May; 253():110-121. PubMed ID: 28302581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance by doxorubicin and quinine co-loaded liposomes in tumor cells.
    Shen Q; Qiu L
    J Liposome Res; 2017 Dec; 27(4):293-301. PubMed ID: 27581212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
    Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo.
    Huang C; Huang S; Li H; Li X; Li B; Zhong L; Wang J; Zou M; He X; Zheng H; Si X; Liao W; Liao Y; Yang L; Bin J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):232. PubMed ID: 30231924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D; Li M; Su J; Miao K; Qiu X
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.